{
  "docId": "019dd923-5ca1-7489-b638-e62bea0762fa",
  "docSlug": "78005f3a3554aa50",
  "documentTitle": "Refueling Innovation Engine Vaccines",
  "authorId": "McKinsey",
  "authorName": "McKinsey",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.333,
  "pageNumber": 14,
  "pageCount": 40,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "industry_trends",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "The chart uses a broken axis between 2015 and 2020.",
  "elementsJson": [
    "headline_text",
    "bar_chart_vertical",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b638-e62bea0762fa/14",
  "deckHref": "/decks/019dd923-5ca1-7489-b638-e62bea0762fa",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b638-e62bea0762fa.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-e62bea0762fa#slide-14",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Future growth will depend on further penetration into adult, nosocomial launches, follow on vaccines in major categories, and speed of adoption in emerging markets",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-d3bb-700a-9da5-9839daaa2a36",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.88,
        "x": 0.06,
        "y": 0.19
      },
      "kind": "chart",
      "text": "Bar chart showing vaccine sales in $B from 1996 to 2020",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ec05db1-624a-4a75-bbad-516f7c3a59f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Global vaccine sales: $39-48bn",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-d3bb-700a-9da5-9f53f28bdeed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.18,
        "x": 0.08,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Driving growth vectors: Pediatric (DTaP combo, varicella)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2bc00299-aa91-44a7-8491-5fa8c403d0d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.65,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Future growth will depend on further penetration into adult, nosocomial launches, follow on vaccines in major categories, and speed of adoption in emerging markets",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a2bd1d3-5c7c-423d-a5ef-a2e2d2943100",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.29,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Driving growth vectors: Blockbusters (PCV, Rota, HPV) and flu",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f722d8e9-4d35-4b4e-abe7-7800d5d82dc1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.03,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "SOURCE: Evaluatepharma February 2016",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19e947ba-9e7e-4f7d-8ab2-01d3ce6ff920",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.95,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Global industry growth has also kept pace, and is expected to continue to grow at close to double-digits through 2020",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a5db1a6-1790-4922-a1f3-b8788c8debf3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "title",
      "text": "Global vaccine sales, 1996-2020",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0e46300f-0eb2-4de7-bb99-c27e3c3ab8df",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [
    {
      "metricRaw": "Global vaccine sales",
      "numberRaw": "$39-48bn",
      "numberKind": "money",
      "actionTitle": "Global industry growth has also kept pace, and is expected to continue to grow at close to double-digits through 2020",
      "calloutText": "Future growth will depend on further penetration into adult, nosocomial launches, follow on vaccines in major categories, and speed of adoption in emerging markets",
      "numberScale": null,
      "numberValue": 39,
      "metricFamily": "revenue",
      "numberCurrency": "$"
    }
  ],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 10,
      "beatId": "f9c4c201-1132-446a-ab51-f4f7ca0f8b84",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The deck highlights the challenges to innovation, including declining profitability, increasing time to market, and manufacturing challenges.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}